Evidence map›Paper›PMID 18029553›Full record

ArticleBlood2008

The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity.

Marshall D Behrens, Wolfgang M Wagner, Christopher J Krco, Courtney L Erskine, Kimberly R Kalli, James Krempski, Ekram A Gad, Mary L Disis, Keith L Knutson

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Uric acid: A hypothetical cause of preeclampsia-eclampsia.Nigerian medical journal : journal of the Nigeria Medical Association · 2013
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Marshall D BehrensDepartment of Immunology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Wolfgang M Wagner
Christopher J Krco
Courtney L Erskine
Kimberly R Kalli
James Krempski
Ekram A Gad
Mary L Disis
Keith L Knutson
Mayo Clinic · US

Funding

HLA classl complex expression in breast cancer immunityR01CA113861 · NCI · MAYO CLINIC ROCHESTER · PI KNUTSON, KEITH L. · 2005 to 2009
$1.1M
Ex vivo expansion of HER-2/neu specific T helper cellsK01CA100764 · NCI · UNIVERSITY OF WASHINGTON · PI KNUTSON, KEITH L. · 2004 to 2008
$742k
NCI NIH HHS K01 CA100764NCI NIH HHS K01-CA100764NCI NIH HHS R01 CA113861NCI NIH HHS R01-CA113861
6 · The paper itself

Abstract

Studies have shown that the immune system can recognize self-antigens under conditions (eg, cell injury) in which the self-tissue might elaborate immune-activating endogenous danger signals. Uric acid (UA) is an endogenous danger signal recently identified to be released from dying cells. Prior work has shown that UA activates immune effectors of both the innate and adaptive immune system, including neutrophils and cytotoxic T-cell immunity. However, it was unclear whether UA could enhance antibody immunity, which was examined in this study. When added to dying tumor cells or with whole protein antigen, UA increased IgG1-based humoral immunity. Further, UA blocked growth of tumor in subsequent tumor challenge experiments, which depended on CD4, but not CD8, T cells. Sera derived from UA-treated animals enhanced tumor growth, suggesting it had little role in the antitumor response. UA did not signal for T-cell expansion or altered tumor-infiltrating leukocyte populations. Consistent with the lack of T-cell expansion, when applied to dendritic cells, UA suppressed T-cell growth factors but up-regulated B cell-activating cytokines. Understanding the nature of endogenous danger signals released from dying cells may aid in a better understanding of mechanisms of immune recognition of self.

Indexed as

AnimalsAntibodiesCell DifferentiationCell Line, TumorCrystallizationInterleukin-5LeukocytesMiceNeoplasmsSignal TransductionUric AcidAntibodiesInterleukin-5Uric Acid

Identifiers

PMID18029553
PMCPMC2214762
OpenAlexW2033219827

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.